{"entity":{"type":"insider","cik":"0001825398","url":"/insider/0001825398","json_url":"/insider/0001825398.json","name":"BIOS Actuate Co-Invest II, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":3,"first":"2024-08-14","last":"2025-06-30","span_basis":"filed_date"},"name_variants":[{"name":"BIOS Actuate Co-Invest II, LP","source":"filing","n_filings":3,"first_seen":"2024-08-14","last_seen":"2025-06-30"}],"transactions":[{"id":4986683,"accession":"0001104659-25-063991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-063991","line_url":"/filing/0001104659-25-063991#line-1","is_derivative":false,"issuer_cik":"0001652935","issuer_name":"ACTUATE THERAPEUTICS, INC.","issuer_ticker":"ACTU","issuer_name_source":null,"issuer_url":"/issuer/0001652935","owner_cik":null,"owner_name":"Bios Actuate Co-Invest III, LP; BIOS Fund III, LP; BIOS Fund III QP, LP; BIOS Equity Partners III, LP; BIOS Capital Management, LP; BIOS Actuate Co-Invest II, LP; BIOS Advisors GP, LLC; BIOS Actuate Co-Invest I, LP; BIOS Fund III NT, LP; Fletcher Aaron G.L.","owner_display_name":"Bios Actuate Co-Invest III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71428.0,"shares_display":"71,428","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":499996.0,"total_display":"499,996.00","total_whole":"499,996","shares_owned_after":196428.0,"shares_owned_after_display":"196,428","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-06-30","scope":"insider"},{"id":9223891,"accession":"0001104659-24-091371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-091371","line_url":"/filing/0001104659-24-091371","is_derivative":false,"issuer_cik":"0001652935","issuer_name":"ACTUATE THERAPEUTICS, INC.","issuer_ticker":"ACTU","issuer_name_source":null,"issuer_url":"/issuer/0001652935","owner_cik":null,"owner_name":"BIOS Actuate Co-Invest I, LP; BIOS Actuate Co-Invest II, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Equity Partners III, LP; BIOS Fund III NT, LP; BIOS Fund III QP, LP; BIOS Fund III, LP; Bios Actuate Co-Invest III, LP; Fletcher Aaron G.L.","owner_display_name":"BIOS Actuate Co-Invest I, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24999.0,"shares_display":"24,999","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":199992.0,"total_display":"199,992.00","total_whole":"199,992","shares_owned_after":980433.0,"shares_owned_after_display":"980,433","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-20","scope":"insider","n_lines":3},{"id":2837581,"accession":"0001104659-24-089822","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001104659-24-089822","line_url":"/filing/0001104659-24-089822","is_derivative":false,"issuer_cik":"0001652935","issuer_name":"ACTUATE THERAPEUTICS, INC.","issuer_ticker":"ACTU","issuer_name_source":null,"issuer_url":"/issuer/0001652935","owner_cik":null,"owner_name":"BIOS Fund III, LP; BIOS Fund III QP, LP; BIOS Equity Partners III, LP; Bios Actuate Co-Invest III, LP; BIOS Fund III NT, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Actuate Co-Invest I, LP; Fletcher Aaron G.L.; BIOS Actuate Co-Invest II, LP","owner_display_name":"BIOS Fund III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24999.0,"shares_display":"24,999","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":224991.0,"total_display":"224,991.00","total_whole":"224,991","shares_owned_after":980433.0,"shares_owned_after_display":"980,433","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-14","scope":"insider","n_lines":3},{"id":2837570,"accession":"0001104659-24-089822","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001104659-24-089822","line_url":"/filing/0001104659-24-089822","is_derivative":false,"issuer_cik":"0001652935","issuer_name":"ACTUATE THERAPEUTICS, INC.","issuer_ticker":"ACTU","issuer_name_source":null,"issuer_url":"/issuer/0001652935","owner_cik":null,"owner_name":"BIOS Fund III, LP; BIOS Fund III QP, LP; BIOS Equity Partners III, LP; Bios Actuate Co-Invest III, LP; BIOS Fund III NT, LP; BIOS Advisors GP, LLC; BIOS Capital Management, LP; BIOS Actuate Co-Invest I, LP; Fletcher Aaron G.L.; BIOS Actuate Co-Invest II, LP","owner_display_name":"BIOS Fund III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":1259427.0,"shares_owned_after_display":"1,259,427","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-14","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001652935","name":"ACTUATE THERAPEUTICS, INC.","url":"/issuer/0001652935","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2024-08-14","last_seen":"2025-06-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001825398","retrieved_at":"2026-08-23T10:36:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}